10x Genomics to Report First Quarter Financial Results on May 5, 2021
10x Genomics (Nasdaq: TXG) will release its Q1 2021 financial results on May 5, 2021, after market close. A live webcast is scheduled for 1:30 PM PT to discuss these results along with business developments and future outlook. The webcast will be accessible through the company's website and will be archived for at least 45 days. 10x Genomics focuses on providing innovative life science technology solutions that enhance biological research and has a robust patent portfolio.
- Scheduled Q1 2021 earnings report could indicate financial health.
- Broad adoption of 10x Genomics products by top global research institutions and pharmaceutical companies.
- None.
PLEASANTON, Calif., April 08, 2021 (GLOBE NEWSWIRE) -- 10x Genomics (Nasdaq: TXG) today announced it will report financial results for the first quarter 2021 after market close on Wednesday, May 5th, 2021. The company’s management will webcast a corresponding conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time to discuss its results, business developments and outlook.
Live audio of the webcast will be available on the “Investors” section of the company website at: www.10xgenomics.com. The webcast will be archived and available for replay for at least 45 days after the event.
About 10x Genomics
10x Genomics is a life science technology company building products to interrogate, understand and master biology to advance human health. The company’s integrated solutions include instruments, consumables and software for analyzing biological systems at a resolution and scale that matches the complexity of biology. 10x Genomics products have been adopted by researchers around the world, including all of the top 100 global research institutions, as ranked by Nature in 2019, and all of the top 20 global pharmaceutical companies, as ranked by 2019 research and development spend, and have been cited in over 2,250 research papers on discoveries ranging from oncology to immunology, and neuroscience. The company’s patent portfolio comprises more than 1,000 patents and patent applications.
Disclosure Information
10x Genomics uses filings with the Securities and Exchange Commission, its website (www.10xgenomics.com), press releases, public conference calls, public webcasts and its social media accounts as means of disclosing material non-public information and for complying with its disclosure obligations under Regulation FD.
Contacts
Media:
media@10xgenomics.com
Investors:
investors@10xgenomics.com
FAQ
When will 10x Genomics announce its Q1 2021 financial results?
What time is the 10x Genomics conference call on May 5, 2021?
How can I listen to the 10x Genomics Q1 earnings call?
What is the ticker symbol for 10x Genomics?
